. 1947 Apr 30;30(3):766-8.

[Androsten- (9) -dion (3.17); Bemerkungen zu H. Reich und A. Lardon, Androsten- (9) -ol- (3beta) -on- (17)]

[Article in German]

[Article in German]

C W SHOPPEE. Helv Chim Acta. 1947.

. 1947 Apr 30;30(3):766-8.

No abstract available

Similar articles

Biotransformation XLVII: transformations of 5-ene steroids in Fusarium culmorum culture.
Kołek T. Kołek T. J Steroid Biochem Mol Biol. 1999 Nov;71(1-2):83-90. doi: 10.1016/s0960-0760(99)00123-5. J Steroid Biochem Mol Biol. 1999. PMID: 10619360
Cholesterol oxidase susceptibility of cholesterol and 5-androsten-3 beta-ol in pure sterol monolayers and in mixed monolayers containing 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine.
Slotte JP. Slotte JP. Biochim Biophys Acta. 1992 Feb 20;1124(1):23-8. doi: 10.1016/0005-2760(92)90121-b. Biochim Biophys Acta. 1992. PMID: 1543722
Over-the-counter delta5 anabolic steroids 5-androsen-3,17-dione; 5-androsten-3beta, 17beta-diol; dehydroepiandrosterone; and 19-nor-5-androsten-3,17-dione: excretion studies in men.
Uralets VP, Gillette PA. Uralets VP, et al. J Anal Toxicol. 2000 Apr;24(3):188-93. doi: 10.1093/jat/24.3.188. J Anal Toxicol. 2000. PMID: 10774538
Dermatochirurgie bei Kindern: Gegenwärtiger Stand zu Indikation, Anästhesie, Analgesie und potentiellen perioperativen Komplikationen.
Crisan D, Scharffetter-Kochanek K, Kastler S, Crisan M, Manea A, Wagner K, Schneider LA. Crisan D, et al. J Dtsch Dermatol Ges. 2018 Mar;16(3):268-277. doi: 10.1111/ddg.13451_g. J Dtsch Dermatol Ges. 2018. PMID: 29537145 Review.
Aktuelle Optionen zur Behandlung pathologischer Narben.
Poetschke J, Gauglitz GG. Poetschke J, et al. J Dtsch Dermatol Ges. 2016 May;14(5):467-78. doi: 10.1111/ddg.13027_g. J Dtsch Dermatol Ges. 2016. PMID: 27119466 Review.

C(14)-substituted corticosteroids; some D ring transformations in the compound S series.
BLOOM BM, AGNELLO EJ, LAUBACH GD. BLOOM BM, et al. Experientia. 1956 Jan 15;12(1):27-30. doi: 10.1007/BF02156992. Experientia. 1956. PMID: 13305572 No abstract available.